Clinical trial
Efficacy And Safety Of Clopidogrel In Neonates /Infants With Systemic To…
NCT00396877 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00396877 |
|---|---|
| Title | Efficacy And Safety Of Clopidogrel In Neonates /Infants With Systemic To Pulmonary Artery Shunt Palliation |
| Official title | International Randomized Double Blind Study Evaluating the Efficacy and the Safety of Clopidogrel 0.2 mg/kg Once Daily Versus Placebo in Neonates and Infants With Cyanotic Congenital Heart Disease Palliated With Systemic to Pulmonary Artery Shunt |
| Acronym | CLARINET |
| Lead sponsor | Sanofi, Industry |
| Collaborators | Bristol-Myers Squibb Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Heart Defects, Congenital |
| Intervention type | Drug |
| Interventions | Clopidogrel (SR25990), placebo |
| Enrollment | 906 |
| Start date | Nov 1, 2006 |
| Primary completion | Feb 1, 2010 |
| Completion | Feb 1, 2010 |
| First posted | Nov 8, 2006 |
| Last update posted | Oct 24, 2014 |
| Countries | Argentina, Belgium, Brazil, Canada, China, Denmark, Egypt, Finland, France, Germany, Hong Kong, Hungary and 19 more |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: